{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2016-P-4584\" sorted by posted_date descending", "rows": [["FDA-2016-P-4584-0012", "FDA", "FDA-2016-P-4584", "Response letter from FDA CDER to Public Citizen's Health Research Group", "Other", "Response(s)", "2017-08-07T04:00:00Z", 2017, 8, "2017-08-07T04:00:00Z", null, "2017-08-07T18:45:27Z", null, 0, 0, "09000064829cacf7"], ["FDA-2016-P-4584-0011", "FDA", "FDA-2016-P-4584", "Glucuronidation Converts Clopidogrel to a Strong Time-Dependent Inhibitor of CYP2C8: A Phase II Metabolite as a Perpetrator of Drug\u2013Drug\nInteractions re Citizen Petition from Public Citizens Health Research Group", "Supporting & Related Material", "Background Material", "2016-12-28T05:00:00Z", 2016, 12, null, null, "2016-12-28T21:50:35Z", null, 0, 0, "090000648243b759"], ["FDA-2016-P-4584-0001", "FDA", "FDA-2016-P-4584", "Citizen Petition from Public Citizens Health Research Group", "Other", "Citizen Petition", "2016-12-28T05:00:00Z", 2016, 12, "2016-12-28T05:00:00Z", "2017-05-31T03:59:59Z", "2016-12-28T21:49:56Z", null, 0, 0, "090000648243b3c0"], ["FDA-2016-P-4584-0007", "FDA", "FDA-2016-P-4584", "Clopidogrel - 2016-09 re Citizen Petition from Public Citizens Health Research Group", "Supporting & Related Material", "Background Material", "2016-12-28T05:00:00Z", 2016, 12, null, null, "2016-12-28T21:50:20Z", null, 0, 0, "090000648243b755"], ["FDA-2016-P-4584-0008", "FDA", "FDA-2016-P-4584", "Health Canada Warning Repaglinide Jul 2015 re Citizen Petition from Public Citizens Health Research Group", "Supporting & Related Material", "Background Material", "2016-12-28T05:00:00Z", 2016, 12, null, null, "2016-12-28T21:50:23Z", null, 0, 0, "090000648243b756"], ["FDA-2016-P-4584-0006", "FDA", "FDA-2016-P-4584", "Carilion-Prandin Label Aug 2016 re Citizen Petition from Public Citizens Health Research Group", "Supporting & Related Material", "Background Material", "2016-12-28T05:00:00Z", 2016, 12, null, null, "2016-12-28T21:50:17Z", null, 0, 0, "090000648243b754"], ["FDA-2016-P-4584-0004", "FDA", "FDA-2016-P-4584", "Canadian drug label - clopidogrel 2016-06 re Citizen Petition from Public Citizens Health Research Group", "Supporting & Related Material", "Background Material", "2016-12-28T05:00:00Z", 2016, 12, null, null, "2016-12-28T21:50:11Z", null, 0, 0, "090000648243b3c5"], ["FDA-2016-P-4584-0009", "FDA", "FDA-2016-P-4584", "Clarification of the Mechanism of Clopidogrel-Mediated Drug-Drug Interaction in a Clinical Cassette Small-dose Study and Its Prediction re Citizen Petition from Public Citizens Health Research Group", "Supporting & Related Material", "Background Material", "2016-12-28T05:00:00Z", 2016, 12, null, null, "2016-12-28T21:50:27Z", null, 0, 0, "090000648243b757"], ["FDA-2016-P-4584-0003", "FDA", "FDA-2016-P-4584", "BMS-Plavix Label Sept 2016 re Citizen Petition from Public Citizens Health Research Group", "Supporting & Related Material", "Background Material", "2016-12-28T05:00:00Z", 2016, 12, null, null, "2016-12-28T21:50:07Z", null, 0, 0, "090000648243b3c4"], ["FDA-2016-P-4584-0002", "FDA", "FDA-2016-P-4584", "Acknowledgement Letter from FDA DDM to Public Citizens Health Research Group", "Other", "Acknowledgement Letter/Receipt", "2016-12-28T05:00:00Z", 2016, 12, "2016-12-28T05:00:00Z", null, "2016-12-28T21:50:00Z", null, 0, 0, "090000648243b3c2"], ["FDA-2016-P-4584-0005", "FDA", "FDA-2016-P-4584", "Canadian drug label - repaglinide 2016-04 re Citizen Petition from Public Citizens Health Research Group", "Supporting & Related Material", "Background Material", "2016-12-28T05:00:00Z", 2016, 12, null, null, "2016-12-28T21:50:14Z", null, 0, 0, "090000648243b753"], ["FDA-2016-P-4584-0010", "FDA", "FDA-2016-P-4584", "Repaglinide - 2016-08 re Citizen Petition from Public Citizens Health Research Group", "Supporting & Related Material", "Background Material", "2016-12-28T05:00:00Z", 2016, 12, null, null, "2016-12-28T21:50:30Z", null, 0, 0, "090000648243b758"]], "truncated": false, "filtered_table_rows_count": 12, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2016-P-4584"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2016-P-4584", "results": [{"value": "FDA", "label": "FDA", "count": 12, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-P-4584&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2016-P-4584", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 9, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-P-4584&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-P-4584&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2016-P-4584", "results": [{"value": 2016, "label": 2016, "count": 11, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-P-4584&posted_year=2016", "selected": false}, {"value": 2017, "label": 2017, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-P-4584&posted_year=2017", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-P-4584&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-P-4584&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-P-4584&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-P-4584&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-P-4584&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-P-4584&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-P-4584&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-P-4584&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 1781.396854086779, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}